Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

By Hyon K. Choi, Miguel A. Hern'an, J. Seeger, James M. Robins, F. Wolfe. The Lancet, 2002

1,179 citations recorded by the source corpus.

Subfields: Nephrology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/4d061a3efe7f2923620b3bc0e751b64ce5efd4df

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. K. Michaud
2. Dorothy Sommer
3. S. Jenisch
4. S. Gabriel
5. E. Christophers
6. M. Suchan
7. M. Weichenthal

Citations in the corpus

• Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis (2006, positive): “Therapeutical intervention by use of anti-inXammatory drugs including methotrexate (MTX) and TNF antagonists seems to diminish the risk [ 3 , 11].”
• Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases (2009, background): “8), although lesser powered studies have recently hinted at a similar effect of anti-tumor necrosis factor (TNF) treatment [7,16,28,29].”